Momenta Pharmaceuticals (MNTA) gains 5.7% AH after announcing it has entered into a...
Thursday, December 22, 2011, 4:32 PM ETMomenta Pharmaceuticals (MNTA) gains 5.7% AH after announcing it has entered into a collaboration with Baxter (BAX) to develop a class of drugs called biosimilars. As part of the deal, Baxter will make a $33M up-front payment to Momenta related to the development of six drug compounds, and "may make additional payments over the next several years."
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles